Literature DB >> 12623186

Microemulsions for topical delivery of estradiol.

S Peltola1, P Saarinen-Savolainen, J Kiesvaara, T M Suhonen, A Urtti.   

Abstract

Estradiol has been widely used for the treatment of hormonal insufficiencies. Due to its extensive first pass metabolism after oral administration, transdermal administration of estradiol in gels and emulsions has been used to improve its bioavailability, prolong activity and to optimize metabolic profile. The purpose of this study was to investigate microemulsions as delivery systems for estradiol. Various o/w microemulsions were used to deliver estradiol across human abdominal skin in vitro. Trasdermal flux of estradiol was determined using Franz-type diffusion cells and the samples were analyzed by high-performance liquid chromatography (HPLC). The permeation data showed that microemulsion formulations increased estradiol flux 200-700-fold over the control, but permeability coefficients were decreased by 5-18 times. The superior transdermal flux of estradiol was due to 1500-fold improvement in solubilization of estradiol by microemulsions. The results suggest that microemulsions are potential vehicles for improved topical delivery of estradiol. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623186     DOI: 10.1016/s0378-5173(02)00632-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  31 in total

1.  Preparation and anesthetic properties of propofol microemulsions in rats.

Authors:  Timothy E Morey; Jerome H Modell; Dushyant Shekhawat; Todd Grand; Dinesh O Shah; Nikolaus Gravenstein; Susan P McGorray; Donn M Dennis
Journal:  Anesthesiology       Date:  2006-06       Impact factor: 7.892

2.  Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery.

Authors:  Fahima M Hashem; Dalia S Shaker; Mohamed Khalid Ghorab; Mohamed Nasr; Aliaa Ismail
Journal:  AAPS PharmSciTech       Date:  2011-07-02       Impact factor: 3.246

3.  Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Dharmik M Mehta; Pragna K Shelat
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

4.  Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Mukesh C Gohel; Pragna K Shelat
Journal:  AAPS PharmSciTech       Date:  2011-12-22       Impact factor: 3.246

5.  Design and characterization of microemulsion systems for naproxen.

Authors:  Eskandar Moghimipour; Anayatollah Salimi; Soroosh Eftekhari
Journal:  Adv Pharm Bull       Date:  2013-02-07

6.  Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: effect on microstructure and physical parameters.

Authors:  S K Mehta; Gurpreet Kaur; K K Bhasin
Journal:  Pharm Res       Date:  2007-06-19       Impact factor: 4.200

7.  Characterisation and Skin Distribution of Lecithin-Based Coenzyme Q10-Loaded Lipid Nanocapsules.

Authors:  Huafeng Zhou; Yang Yue; Guanlan Liu; Yan Li; Jing Zhang; Zemin Yan; Mingxing Duan
Journal:  Nanoscale Res Lett       Date:  2010-07-20       Impact factor: 4.703

8.  Microemulsion system with improved loading of piroxicam: a study of microstructure.

Authors:  Muhammad Faizan Nazar; Asad Muhammad Khan; Syed Sakhawat Shah
Journal:  AAPS PharmSciTech       Date:  2009-10-30       Impact factor: 3.246

9.  Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.

Authors:  Gitanjali Sharma; Anil Kumar Mishra; Pushpa Mishra; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2009-11-06       Impact factor: 3.246

10.  Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects.

Authors:  H Yeşim Karasulu; Z Evren Sanal; Sumru Sözer; Tamer Güneri; Gökhan Ertan
Journal:  AAPS PharmSciTech       Date:  2008-02-14       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.